Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Examine the impact of insulin suppression on embryo H3K27 trimethylation.

ABSTRACT: These expeirments compare the H3L27-trimethylation ChIP profiles for embryonic progeny of GFP expressing (control) and InR-DN expressing stage 14 oocytes.

ORGANISM(S): Drosophila melanogaster

PROVIDER: GSE157387 | GEO | 2021/07/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Examine the impact of insulin suppression on embryo H3K27-ac

Project description:These expeirments compare the H3k27-ac ChIP profiles for embryonic progeny of GFP expressing (control) and InR-DN expressing stage 14 oocytes.

2021-07-01 | GSE175754 | GEO

Examine the impact of insulin suppression on embryo H3K9m-me3

Project description:These expeirments compare the H3K9m-me3 ChIP profiles for embryonic progeny of GFP expressing (control) and InR-DN expressing stage 14 oocytes.

2021-07-01 | GSE175755 | GEO

Examine the impact of germ line insulin suppression on embryo gene expression.

Project description:These expeirments compare the polyA selected RNA isolated from progeny 16-20hr old embryos from GFP expressing (control) and InR-DN expressing oocytes.

2021-07-01 | GSE145352 | GEO

Examine the impact of insulin suppression on oocyte gene expression.

Project description:These expeirments compare the polyA selected RNA isolated from GFP expressing (control) and InR-DN expressing stage 14 oocytes.

2021-07-01 | GSE145351 | GEO

Examine the impact of insulin suppression on embryo H3K27 trimethylation.

Project description:Examine the impact of insulin suppression on embryo H3K27 trimethylation.

| PRJNA661095 | ENA

Examination of H3k27-me3, H3k27-ac, and H3k9-me3 in recurrent MCF7 cells

Project description:These expeirments compare the chnages in h3K27-me3, H3k27-ac, and H3K9-me3 levels that occur in recurrent MCF7 cells.

2021-07-01 | GSE175753 | GEO

Examine the impact of insulin suppression on embryo H3K27-ac

Project description:Examine the impact of insulin suppression on embryo H3K27-ac

| PRJNA733488 | ENA

Examine the impact of insulin suppression on embryo

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-07-01 | GSE175756 | GEO

Dynamic regulation of H3K27 trimethylation during Arabidopsis differentiation.

Project description:During growth of multicellular organisms, identities of stem cells and differentiated cells need to be maintained. Cell fate is epigenetically controlled by the conserved Polycomb-group (Pc-G) proteins that repress their target genes by catalyzing histone H3 lysine 27 trimethylation (H3K27me3). Although H3K27me3 is associated with mitotically stable gene repression, a large fraction of H3K27me3 target genes are tissue-specifically activated during differentiation processes. However, in plants it is currently unclear whether H3K27me3 is already present in undifferentiated cells and dynamically regulated to permit tissue-specific gene repression or activation. We used whole-genome tiling arrays to identify the H3K27me3 target genes in undifferentiated cells of the shoot apical meristem and in differentiated leaf cells. Hundreds of genes gain or lose H3K27me3 upon differentiation, demonstrating dynamic regulation of an epigenetic modification in plants. H3K27me3 is correlated with gene repression, and its release preferentially results in tissue-specific gene activation, both during differentiation and in Pc-G mutants. We further reveal meristem- and leaf-specific targeting of individual gene families including known but also likely novel regulators of differentiation and stem cell regulation. Interestingly, H3K27me3 directly represses only specific transcription factor families, but indirectly activates others through H3K27me3-mediated silencing of microRNA genes. Furthermore, H3K27me3 targeting of genes involved in biosynthesis, transport, perception, and signal transduction of the phytohormone auxin demonstrates control of an entire signaling pathway. Based on these and previous analyses, we propose that H3K27me3 is one of the major determinants of tissue-specific expression patterns in plants, which restricts expression of its direct targets and promotes gene expression indirectly by repressing miRNA genes.

| S-EPMC3072373 | biostudies-literature

Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation.

Project description:Metformin has been used for the treatment of type II diabetes mellitus for decades. Recently, used of metformin in the therapy of diverse human cancer types has received widespread attention, while the underlying mechanisms have been not fully elucidated. In the current study, 5-ethynyl-20-deoxyuridine assay to detect cell proliferation, flow cytometry to detect apoptosis, scratch wound healing and Transwell migration assay to detect cell migration capacity. The current study reported that metformin inhibited cell proliferation and migration, and promoted apoptosis in ovarian cancer cells, particularly under normoglycemic conditions in vitro. Metformin treatment significantly promoted the phosphorylation of AMP-activated protein kinase (AMPK), and reduced histone H3 lysine 27 trimethylation (H3K27me3) and polycomb repressor complex 2 (PRC2) levels. Additionally, overexpression of EZH2 to increase H3K27me3 abrogated the effect of metformin on the cell proliferation, migration and apoptosis in SKOV3 and ES2 cells. Similar to metformin, another AMPK agonist, 2-deoxy-D-glucose, reduced the H3K27me3 level and PRC2 expression. In cells pretreated with Compound C, an AMPK inhibitor, metformin was not able to induce AMPK phosphorylation or reduce H3K27me3. Metformin-mediated AMPK activation and H3K27me3 inhibition were more robust in cells exposed to low glucose (5.5 mM) compared with those exposed to high glucose (25 mM). These findings implicate H3K27me3 repression mediated by AMPK phosphorylation in the antitumor effect of metformin in ovarian cancer, indicating that metformin alters epigenetic modifications by targeting PRC2 and supports the use of metformin in treatment of patients with epithelial ovarian cancer without diabetes.

| S-EPMC5919713 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data